ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

December 31, 2006

Conditions
Heart Failure, Congestive
Interventions
DRUG

ZP120

PROCEDURE

I.v. catherization

PROCEDURE

6-minutes walk performance

BEHAVIORAL

Dyspnea severity assessment

PROCEDURE

Blood sampling for laboratory tests

PROCEDURE

ECG

PROCEDURE

Physical examination

Trial Locations (22)

14618

University of Rochester Medical Center, Rochester

17603

Lancaster Heart Foundation, Lancaster

19141

Albert Einstein Medical Center, Philadelphia

21201

University of Maryland, Baltimore

30322

Emory University Hospital/The Emory Clinic, Atlanta

30342

Northside Hospital, Atlanta

32901

Health First Clinical Research Institute, Melbourne

33136

Univ. of Miami Miller School of Medicine, Jackson Memorial Medical Center, Miami

44195

Cleveland Clinic Foundation, Cleveland

46011

Community Hospital Anderson/Community Clinical Research Center, Anderson

48202

Henry Ford Hospital, Detroit

52242

University of Iowa Heart Failure Treatment Program, Iowa City

55415

Hennepin County Medical Center, Minneapolis

59802

The International Heart Institute, Missoula

60612

Rush University Medical Center, Chicago

68510

Bryan LGH Heart Institute, Lincoln

78212

Alamo Clinical Research Associates, San Antonio

90073

LAC-USC Medical Center-Division of Cardiology, Los Angeles

VA Medical Center -WLA, Los Angeles

94121

San Francisco VA Medical Center, San Francisco

123456

University of CO Health Sciences Center, Denver

92103-8411

UCSD Medical Center, San Diego

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Zealand Pharma

INDUSTRY